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The nonreceptor tyrosine kinase Itk plays a key role in TCR-initiated signaling that directly and signiﬁcantly aﬀects the regulation
of PLCγ1 and the consequent mobilization of Ca2+. Itk also participates in the regulation of cytoskeletal reorganization as well
as cellular adhesion, which is necessary for a productive T cell response. The functional cellular outcome of these molecular
regulationsbyItkrendersitanimportantmediatorofTcelldevelopmentanddiﬀerentiation.Thispaperencompassesthestructure
of Itk, the signaling parameters leading to Itk activation, and Itk eﬀects on molecular pathways resulting in functional cellular
outcomes. The incorporation of these factors persuades one to believe that Itk serves as a modulator, or rheostat, critically ﬁne-
tuning the T cell response.
1.Introduction
Normal T lymphocyte activation occurs through its antigen
receptor leading to various signaling cascades and ending in
a certain function. These activating signaling cascades are
exquisitely balanced, as diﬀerent signals can lead to many
diﬀerent functional outcomes. Inappropriate signaling or
skewed signals can cause many problems for the T cell and
for a functional immune system. Aberrant T cell function
can induce many devastating diseases such as leukemia and
autoimmune disorders.
When a T cell encounters an antigen-presenting cell
(APC), it must be able to discriminate whether or not the
APC is functional. This occurs through physical interaction
between surface molecules of the APC and T cell, translating
that information into a response. This requires many coordi-
nated molecular interactions from the cell surface, through
thecytoplasm,ontothenucleus,andinsomeinstances,back
outthroughthecellsurfaceagain[1].Anillustrationofthisis
showninFigure 1.Atthecellsurface,interactionbetweenthe
peptide-loaded major histocompatibility complex (pMHC)
of class II or class I on the APC with the T cell receptor
(TCR) on the T cell coordinates with coreceptor binding
of CD4 on helper T cells or CD8 on cytotoxic T cells,
respectively. This interaction causes the dissociation and
activationofthetyrosinephosphataseCD45fromCD4/CD8,
which dephosphorylates CD4/CD8 bound Src kinase Lck on
its inhibitory tyrosine (tyrosine 505). With activated Lck
in tow, CD4/CD8 co-receptor pulls Lck into proximity of
the TCR/CD3 complex. Lck then phosphorylates the intra-
cellular tyrosine activation motifs (ITAMs) within the CD3
complex. Phosphorylation of the CD3 ITAMs promotes the
docking of other molecules to the CD3 complex, namely the
zeta-associated protein of 70 kilodaltons (ZAP-70) which is
also phosphorylated by Lck for its activation [2, 3]. Activated
ZAP-70 then phosphorylates the linker for activated T cells,
or LAT, a transmembrane and palmitoylated adaptor that
bridges the initial TCR signal to many downstream signaling
events [4].
Phosphorylation of LAT is paramount for subsequent
signaling due to the critical nature of the proteins bind-
ing to it [5]. Another cytoplasmic adaptor molecule, the
SH2 domain containing leukocyte phosphoprotein of 76
kilodaltons (SLP-76), binds to LAT through Gads where it
becomesphosphorylatedbyZAP-70[6].SLP-76bindstoand
inducibly recruits many other cytoplasmic molecules to the
activated LAT complex, including PLCγ1, ADAP, Nck, and
Itk, the subject of this paper [7]. LAT-recruited Itk becomes
transphosphorylated at the membrane by Lck on its activa-
tion tyrosine (tyrosine 511), and then autophosphorylates2 Journal of Signal Transduction
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Figure 1: T cell receptor activated signal transduction pathways. Cartoon diagram of the critical protein interactions necessary for the
activation of a T cell when engaging an antigen-presenting cell.
itself on tyrosine 180 for full activation [8]. Activated Itk
phosphorylates PLCγ1 on tyrosines 775 and 783 leading to
the activation of this lipase [9–11].
Itk-activated PLCγ1 cleaves membrane phosphatidyl
inositol (4,5) bisphosphate (PIP2) into two secondary mes-
sengers, inositol 1,4,5-trisphosphate (IP3) and diacylglycerol
(DAG).IP3 diﬀusesintothecytoplasmtobinditscognateIP3
receptors (IP3R) on the endoplasmic reticulum (ER) leading
to the release of calcium in the cytoplasm [12]. Cytoplasmic
Ca2+ binds calmodulin, causing its inhibitory release from
calcineurin, freeing this phosphatase to dephosphorylate
cytoplasmic localized nuclear factor of activated T cells
(NFAT). NFAT then translocates into the nucleus to perform
its transcription factor duties of genetic regulation [13]. The
otherPLCγ1-generatedsecondarymessenger,DAG,activates
protein kinase C theta (PKCθ), which leads to the release of
the nuclear factor of kappa light chain enhancer in B cells
(NFκB) into the nucleus to perform its transcription factor
duties [14, 15]. DAG also promotes the phosphorylation of
Ras guanyl releasing protein (RasGRP), a GTP exchange fac-
tor (GEF) that activates Ras, leading to the downstream acti-
vation of mitogen-activated protein kinase (MAPK) path-
ways [16], the MAPKs jun-N-terminal kinase (JNK) and p38
phosphorylate Jun and Fos, respectively, prompting them to
translocate into the nucleus and combine to form the AP-1
transcription factor important for genetic regulation [17].
The TCR-activated, LAT-bridged, SLP-76 signalosome
brings in two more players important for the sustained
activation of the T cell necessary for its full response.
These two molecules are the adhesion- and degranulation-
promoting adaptor protein (ADAP) and noncatalytic region
of tyrosine kinase (Nck). ADAP is an adaptor protein that
leads to the intracellular activation of extracellular integrin
adhesion molecules, in a process termed as “inside-out”Journal of Signal Transduction 3
signaling[18–20].IntegrinactivationhelpstomaintainTcell
contact with the APC for an extended period to allow full T
cell response to the presented antigen [21] .N c ki sa na d a p t o r
that brings the cytoskeleton organizing molecule, Wiskott-
Aldrich syndrome protein (WASp), to the proximity of the
SLP-76 signalosome [22, 23]. WASp is indirectly activated
through the GEF Vav1. Vav1 exchanges GTP for GDP for
Rho GTPases, particularly that of Cdc42, which in the GTP-
bound conformation binds to and activates WASp. This
causes WASp to destabilize its autoinhibitory condition and
take on an open conformation allowing the Arp2/3 complex
to bind and seed actin polymerization [24]. Therefore, active
WASp enables actin to be reorganized at the T cell junction
adjacent to the APC, causing the T cell to stay stably in
contact with the APC for the duration of its response, a
process necessitated by Itk.
The modulator of this TCR-mediated response is Itk,
and as such, the focus of this paper will be on Itk, an
enigmatic kinase that serves as a rheostat for many of the
signaling pathways needed for a full and eﬀective T cell
response. Itk is needed for the regulation of Ca2+ ﬂux,
actin polymerization, integrin binding, and transcriptional
activation. Consequently, it has a profound role in the
development of T cells, cytokine expression, and the clear-
ance of pathogens. The mention of other lymphoid signal
transduction molecules, particularly that of other Tec family
kinases, will only be alluded to as a reference to Itk in order
to highlight the importance of Itk [25, 26].
2. Identiﬁcation of Itk
Interleukin-2 inducible tyrosine kinase was discovered and
cloned by three independent research groups. Stephen
Desiderio’s group was the ﬁrst to identify the gene and
named it Itk (IL-2 Inducible Tyrosine Kinase) [27]. This
was quickly followed by Leslie Berg’s group (T-cell-speciﬁc
tyrosine kinase, Tsk) [28] and Toshiaki Kawakami’s group
(expressed in mast and T cells, emt) [29]. This nearly
simultaneous cloning of the gene and subsequent naming by
three diﬀerent groups led to some conﬂicting nomenclature
initially, but the gene name is now accepted as Itk. This
kinase is a 72-kDa protein expressed in the thymus, spleen,
and lymph nodes. More speciﬁcally, Itk is expressed in T
cells, natural killer cells, natural killer T cells, and mast
cells. It is chromosomally localized to 5q31-32 in humans
[30]. This localization is unique to Itk as other Tec family
kinasesareseeminglyduplicated;Tecandrestinglymphocyte
kinase (Rlk) both are on the 4p12 locus [31], while Bruton’s
tyrosine kinase (Btk) and bone marrow kinase (Bmx) are
both on the X chromosome (albeit separated somewhat, Btk
on Xq22 and Bmx on Xp22 [32]). Evolutionarily, the Tec
kinases have been found in ﬂies (Drosophila melanogaster),
zebraﬁsh (Danio rerio), skates (Raja eglanteria), and in sea
urchins (Anthocidaris crassispina)[ 33]. Two diﬀerent forms
of Itk have been cloned in the mouse, which have six amino
acids either included or deleted [34]. The shorter version
is exclusively detected in human cells. Itk has substantial
eﬀects on T cell development and function, due in large
part to its disproportionate expression levels compared to
other Tec kinases. As measured by qRT-PCR, na¨ ıve mouse
T cells contain 100-fold more copies of Itk compared to Tec,
and 3-fold more copies than that of Rlk [35]. Upon T cell
stimulation, Itk expression is increased, especially in TH2
cells, while Rlk expression is reduced and becomes relegated
to TH1cells[36].Tec expression inT cellsincreases only after
several days of stimulation [37].
3. ProteinStructureof Itk
Itk is a modular protein, consisting of ﬁve distinct structural
domains [38]. At its amino terminus, Itk contains a pleck-
strin homology (PH) domain, which allows the protein to
bind phosphorylated lipids on the membrane. Adjacent to
this is the Tec homology (TH) domain from which comes
Itk’s familial association. This domain contains a polyproline
rich region (PRR) necessary for binding Src homology 3
(SH3) domains. The adjoining domain is a SH3 domain,
which binds to PRR both in cis- (to itself) and in trans-
(to other proteins). The following Src homology 2 (SH2)
domain enables the protein to bind tyrosine-phosphorylated
substrates. At its carboxyl terminus, Itk possesses an Src
homology 1 (SH1) or kinase domain, which speciﬁcally
phosphorylates tyrosine residues, particularly that of PLCγ1
[39]. Itk, as well as the Tec kinases, shares evolutionary
similarities to the Src family kinases in structure. However,
the Tec kinases lack the N-terminal myristoylation sequence
constitutively localizing Src kinases to the membrane and
lack the C-terminal negative regulatory tyrosine residue
present on Src kinases.
3.1. The Pleckstrin Homology (PH) Domain (Amino Acids 5–
112). PH domains are protein-lipid interaction domains of
about 100 amino acids in size, forming a β-barrel from two
β-sheets and a carboxyl-terminal α-helix [40, 41]. A unique
feature of the Tec family tyrosine kinases is the presence of
a PH domain. Rlk is an exception as it contains a cysteine
palmitoylation motif and no PH domain [42]. The PH
domain contains the propensity to bind phospholipids in
many forms, including phosphatidylinositol-3,4,5 triphos-
phate (PIP3), PI(4,5)P2, and PI(4)P, with binding of Itk to
PIP3 at highest aﬃnity. Itk binding to the plasma membrane
through its PH domain is induced through the activity
of PI3K, which phosphorylates PIP2 to PIP3. Addition of
PI3K inhibitors prevents Itk from localizing to the plasma
membrane and becoming active [43–45]. Therefore, Itk is
targeted to the membrane and activated through a PI3K-
dependent mechanism. Interestingly, localization to the
plasma membrane through the PH domain is not enough
for Itk’s activation. Pleckstrin homolgy domain deleted
Itk replaced with a myristoylation sequence enables Itk to
localize to the membrane, but it does not become tyrosine
phosphorylated upon TCR stimulation [43]. These data
indicate that the PH domain contains some other role vital
to Itk’s activation other than simple membrane localization.
PH domain binding to PIP3 localizes Itk in proximity of its
activating kinase, Lck, thereby increasing Itk’s kinase activity
[43, 44, 46]. Also, this domain is integral for binding to
the nuclear membrane when the molecule is shuttled to the4 Journal of Signal Transduction
nucleus [47]. Another unique feature of the Tec kinases is
the presence of a PH domain FYF motif. This motif in Btk
is linked to agammaglobulinaemia in humans; however, this
motif’s function has not yet been addressed in Itk. Although
selective PH domain inhibitors of Btk have been reported,
such as the quinone epoxide terreic acid [48], no selective
PH domain inhibitors of Itk have been reported. Recently,
the PH domain of Itk was shown to bind to inositol-1,3,4,5-
tetrakisphophate (IP4) in vitro with a functional in vivo
consequence [49]. Molecularly, this causes Itk’s disruption of
its inducible localization to the T cell/APC contact site and
for its activation. Cellularly, this creates a phenotype where
thymocytes undergoing positive selection become unable to
progress beyond the CD4+CD8+ double positive stage of
development. This necessitates Itk’s involvement in T cell
development, which requires an alternative role for Itk’s PH
domain. These combined data suggest an intriguing role of
the PH domain of Itk both in its molecular activation and
Itk’s eﬀect on cellular function.
3.2. The Tec Homology (TH) Domain (a.a. 115–163). Itk’s
TH domain contains a familial Tec motif of a conserved
27 a.a. sequence at the amino-terminus of the domain
[50] as well as a proline rich region (PRR) at a.a. 153–
163. This domain is integral to the activity of Itk as it is
thought that this domain binds to its own SH3 domain in an
autoinhibitedstate[51].Disruptionofthisassociation,either
by competitive interaction with another peptide sequence
or by mutation, is surmised to relieve this autoinhibition
and activate the kinase. However, deletion of only the PRR
has an opposite eﬀect, it reduces Itk’s basal activity by 50%
[52]. Additionally, it has been reported that this domain
contains a familial Zn++ binding motif, which is critical for
oligomerization of Itk at the cell surface [53]. As of yet,
no protein has been shown to functionally bind to the TH
domain of Itk. Proteins shown to bind in vitro have later
beenshowntobindindirectlyinvivo,eitherthroughanother
Itk structural domain or through another molecule entirely
[54]. Given the paradoxical naturebetween the structureand
the function of this domain, more work should be done to
identify what the TH domain is doing in Itk.
3.3. The Src Homology 3 (SH3) Domain (a.a. 174–230). SH3
domains allow for protein-protein interactions to proline
peptidesequences(either(R/K)XXPXXPorPXXPXRmotifs,
where X is any amino acid) facilitating protein function
or cellular localization. Not only is the SH3 domain of Itk
involved with the binding of internal and external PRRs,
but it is also involved in the negative regulation of its
own catalytic activity. For example, elimination of the SH3
domain or mutation of a Tec family conserved tryptophan
(W208K) that is required for SH3 binding to PRR causes a
spontaneous activation of the enzyme, presumably through
the release of autoinhibition [55]. Paradoxically, auto-
phosphorylation on tyrosine 180 leads to the activation of
Itk [8,56],soeliminationofthisdomainshouldtheoretically
lead to an inactive condition. However, elimination of this
domain and mutational disruption most likely leads to a
conformationalreleaseofautoinhibition,allowingthekinase
domain to become exposed and catalytically active. It is
also possible that the phosphorylation within this domain
prevents the binding of a repressor protein though no such
protein has been found. There are a plethora of proteins
that bind the SH3 domain of Itk in vitro [57], including
WASp, Sam68, Cbl, SLP-76, and Vav1, many of which have
not been conﬁrmed in vivo. One exception is the recent
report of the in vivo interaction of Itk with SLP-76 [58].
Utilizing a cell-permeable peptide to competitively inhibit
the Itk-SH3 interaction with SLP-76 PRR, Itk activity and
functional T cell response was aﬀected, indicating an impor-
tant role of the Itk-SH3 domain interaction with SLP-76.
The interaction between Itk’s SH3 domain and the nuclear
import chaperone karyopherin α (Rag cohort 1α,R c h 1 α)
leads to Itk’s transport into the nucleus [47]. This interaction
requires Rch1α’s proline 242, as a mutant Rch1α (P242A)
decreased nuclear localization of Itk and diminished IL-2
production. As described later, this is important as Itk not
only serves as a cellular membrane proximal kinase linking
early signal transduction events, but it also serves to regulate
transcriptional activation of certain proteins in the nucleus.
3.4. The Src Homology 2 (SH2) Domain (a.a. 237–329). SH2
domains allow for inducible protein-protein interactions
with phosphotyrosine-containing peptide sequences [59,
60]. Itk’s binding to tyrosine phosphorylated substrates not
only provides the mechanism for it to inducibly interact
with protein partners, but it has shined light on its own
localization and consequent activation. Mutation of the SH2
domain of Itk, either through deletion or point mutation of
the tyrosine binding pocket, leads to the inactivation of Itk
[55]. Itk has been reported to bind to SLP-76 [54, 61], LAT,
[44, 55], and Vav1 [62] through its SH2 domain, although
it has not yet been determined to which of these molecules
the SH2 domain of Itk has a higher aﬃnity. Itk also binds
to PLCγ1 through its SH2 domain, though it is not resolved
a st ow h e t h e ri ti sd i r e c t[ 39], or indirect through SLP-76
[9, 63]. Importantly, it has been shown that Itk is negatively
regulated through its SH2 domain by the prolyl-isomerase
cyclophilin A (CypA), whose binding to Itk can be competed
against by Cyclosporin A leading to Itk’s activation [64].
Peptidylprolyl isomerases, such as CypA, convert proline
peptide bonds to cause a cis- or trans-conformational switch
intheproteinwithwhichitinteracts.CypAbindstoaproline
residue in the SH2 domain of Itk (P287), promoting the
cis-intramolecular interaction with the SH3 domain. This
proline residue switch is unique to Itk, as it is not a shared
phenomenon with the other Tec kinases [65]. When CypA is
relieved of binding to Itk, an isomeric switch within the SH2
domain causes Itk to take on a transconformation, allowing
it to bind to other proteins. These data imply that CypA
is a negative regulator of Itk activity. Consistent with this
idea, T cells deﬁcient for CypA display an overall pattern
of increased signaling in response to TCR stimulation, with
an increase of PLCγ1 phosphorylation in particular [66].
Given the inducible relieving of repression and consequent
functional binding to many key signaling molecules, the SH2
domain of Itk is of vital importance for its activity.Journal of Signal Transduction 5
3.5. The Src Homology 1 (SH1) Domain (a.a. 363–612).
The sting for Itk’s kinase activity resides within its SH1
domain. Herein lies its ATP binding pocket, allowing it
to enzymatically transfer terminal ATP phosphate to its
protein target(s). Also within this domain is tyrosine 511
which needs to become transphosphorylated by Lck for
the initial activation of Itk [67]. X-ray crystal structures
of the kinase domain of Itk have been resolved both in
the non-phosphorylated and in the phosphorylated states
[68]. Interestingly, phosphorylation of tyrosine 511 did not
induce a conformational change in this domain indicating
that although phosphorylation of this residue is required
for the activity of this enzyme, it does not do so through a
phosphorylation-dependent conformational switch. Rather,
phosphorylation of the kinase domain could lead to some
secondary function. Further, the isolated kinase domain of
Itk is similar to the other Tec kinases in that they are
kinetically inactive [69]. This is in stark contrast to any other
SH1 containing kinase. This indicates that other domains of
Itk help to regulate the kinase. Finally, the known targets of
ItkkinasedomaintransphosphorylationarePLCγ1tyrosines
775and783[63],T-bettyrosine525[70],Tim-3tyrosine265
[71], and TFII-I tyrosine 248 [72].
4. Upstream Regulatorsof Itk
The activation of Itk is a complex orchestration of events
(Figure 2). This kinase is activated through a myriad of sur-
face receptors, including the TCR/CD3 signaling complex,
co-receptors, chemokine receptors, and heterotrimeric G-
protein-coupled receptors (GPCRs). Prior to the activation
of the T cell, Itk resides in the cytoplasm in a closed,
autoinhibited state. This inhibitory conformation occurs
through the cisbinding of its SH3 domain to the PRR
of the TH domain [51]. More recently, however, it was
found that the SH2 and SH3 domains of Itk could dimerize
with each other in a trans-head-to-tail manner that could
preclude or mitigate the cis-binding of a single Itk molecule
to itself [73]. Further, it was found that full-length Itk
self-associates intermolecularly [74]. This intermolecular
clustering negatively regulates Itk and, once disrupted, leads
to Itk activity. Continuing to determine the conformational
stateandactivationoffull-lengthItkisofcriticalimportance,
asthe information willbeutilized forinhibitor development.
Itk associates with SLP-76 while in the cytoplasm, and
is shuttled to the membrane-associated LAT signalosome by
SLP-76 upon TCR/CD3 stimulation [54]. While at the LAT
signalosome, Itk becomes phosphorylated at tyrosine 511
of the SH1 domain by Lck [8, 67]. Transphosphorylation
activates Itk kinase activity, whereupon the kinase autophos-
phorylates itself at tyrosine 180 of the SH3 domain [8]. Cis-
phosphorylation fully opens the protein, allowing the PH
domaintobindPI3Kphosphorylatedlipidsatthemembrane
and therefore acts as a fully active kinase within the LAT
signalosome. Cells lacking Lck or containing a mutant Itk
phenylalanine substitution for tyrosine at the transphos-
phorylation position 511 leads to a kinetically inactive Itk
[67]. Further, mutation of Itk at the auto-phosphorylation
site tyrosine 180 to phenylalanine impairs Itk’s activity in
response to stimulation [8]. This Itk auto-phosphorylated
tyrosine lies within the substrate binding sequence of the
SH3 domain [51], leading one to speculate that this tyrosine
regulatory site is not just important for enzymatic activity,
but for protein-protein interactions as well. Similarly, Btk’s
autophosphorylation site at tyrosine 223 only binds to WASp
while in the non-phosphorylated state, but only binds to
Syk while in the phosphorylated state [75]. It would be
reasonable to speculate that Itk acts in a similar fashion.
4.1. T Cell Receptor Activation. TCR engagement leads to
the pivotal activation of two molecules that are integrally
important for the activation of Itk, Lck, and PI3K. Activation
of Lck through the dephosphorylation of its inhibitory
tyrosine by CD45 causes a rapid phosphorylation of receptor
components as well as associating molecules such as ZAP-
70 and downstream adaptor molecules LAT and SLP-76.
Recruitment of Itk to the TCR-nucleated signalosome is
mediated through SLP-76, which brings Itk from the cyto-
plasm to the plasma membrane where Itk PH domain can
bind to PI3K phosphorylated phospholipids [58]. Recruit-
ment by SLP-76 to the ZAP-70 primed LAT signalosome
leadsItktobetransphosphorylatedbyLck.Thiscombination
of events leads to the fully activated state of Itk, one that
is relieved of autoinhibited restraints, and one that can
phosphorylate downstream targets.
4.2. Co-Receptor Activation. Upon CD28 stimulation, Itk
binds to CD28 and becomes tyrosine phosphorylated by Lck
[76–78]. Itk’s interaction with the cytoplasmic polyproline
motif of CD28 through its SH3 domain facilitates both the
activation of Itk and the tyrosine phosphorylation of CD28
on all four tyrosines found in its cytoplasmic tail [79–81].
ThisactivationofItkhelpstoamplifyTCRsignals,whichhas
apr ofoundeﬀectonCa2+ mobilization[82].Thisassociation
was originally proposed to illuminate Itk as a negative regu-
lator of T cell signaling through CD28, as mice lacking Itk
have an increased proliferative response to CD28 stimulation
[83]. However, more recent ﬁndings indicate that Itk is not
essential for CD28 signaling [84]. In this work, investigators
used puriﬁed CD4+ T cells from Itk
−/− mice and noted that
these cells already have an activated or memory phenotype
that becomes enhanced upon stimulation. It was therefore
found that CD28 signaling was normal in Itk
−/− cells and
Itk does not act as a negative regulator of CD28 stimulation.
Similar to the binding of Itk to CD28, Itk has been reported
to bind to the PRR on the cytoplasmic portion of CD2,
e n a b l i n gI t kt ob e c o m ea c t i v a t e db yL c ku p o nC D 2c r o s s -
linking [85, 86]. Itk’s explicit association with these co-
receptors inspire further evaluation as it relates to signal
transduction pathway cross-talk.
4.3. Chemokine and Hetero-Trimeric G-Protein Coupled Re-
ceptors. Both sets of binding G-protein subunits can func-
tionally associate with Itk. The G-protein βγ subunits have
been shown to bind to Itk through Itk’s PH domain and
c a np r o m o t eI t ka cti vi ty[ 87]. Chemokines are small proteins
that are inducibly secreted by resident cells to promote the6 Journal of Signal Transduction
Lck
SLP-76
ZAP-70
CD4
Itk
Itk
Gads
LAT
PH
TH
SH1
SH2
SH3
TCRαβ
PI3K
PIP3
CD3ε
Figure 2: Mode of Itk activation through the T cell receptor. While residing in the cytoplasm, Itk preferentially takes on an inhibited
homodimer conformation and in some instances as an inhibited independent cis-conformation. Upon T cell engagement, Itk is able to
bind SLP-76 through its SH3 domain and shuttled to the LAT signalosome. Once there, activated ZAP-70 phosphorylates SLP-76 on tyrosine
145 which Itk then binds to with its SH2 domain to solidify the connection at the signalosome. At which time Itk localizes to the plasma
membrane by binding PI3K-generated PIP3 with its PH domain and Itk then becomes tyrosine phosphorylated by Lck on tyrosine 511. This
leads to Itk’s catalytic activity that ﬁrst phosphorylates itself on tyrosine 180 culminating in a fully activated enzyme.
recruitment and migration of lymphocytes to an area of
infection.Chemokine stimulation linking G-proteincoupled
receptors to actin polymerization events have shown that Itk
can mobilize to the plasma membrane and become tyrosine
phosphorylated upon Stromal cell-derived Factor 1-alpha
(SDF-1α, also known as CXCL12) chemokine stimulation
[88, 89]. Itk’s response to SDF-1α is sensitive to both
PI3K and pertussis toxin from the bacterium Bordetella
pertussis, which inactivates Gαi. Additionally, overexpression
of Gαtransducin leads to the dominant-negative inhibition of
endogenous Gβγ subunits, which aﬀects recruitment of Itk
to the plasma membrane in HeLa cells [88]. Since PI3K
can be activated through Gβγ, it follows that recruitment of
Itk to the plasma membrane upon chemokine stimulation
is dependent on a Gβγ-PI3K pathway. This was shown
to be true in a recent paper detailing the T cell speciﬁc
adapter protein (TSAd) promoting the migration of T
cells through the interaction of the Gβ subunit, leading to
CXCL12-inducedItkphosphorylation,actinpolymerization,
and cellular migration [90]. The Schwartzberg group also
showed that mutant Itk can block the chemokine-induced
polarization and activation of the Rho GTPases Cdc42 and
Rac [88]. Consistent with the molecular ﬁndings, T cells
from Itk−/− mice are deﬁcient in their ability to home to the
lymph node, and as such, there are reduced numbers of T
cells in the lymph nodes in comparison to the numbers of T
cells in the spleens of these mice [88]. Further, Itk deﬁcient
T cells display an impairment in their ability to migrate to
the lungs in response to CXCR4 ligand [89]. This ﬁnding has
been conﬁrmed in mice treated with a kinase-domain Itk-
speciﬁc inhibitor, whose T cells were also reduced in ability
to home to the lungs [91]. All of the above Itk-activating
pathways coordinate to tune the immune response leading
to downstream eﬀector function.
5.DownstreamItkEffectors
Intriguingly, Itk is a known activator of many diﬀerent
downstream targets leading not only to the immediate
activation of certain signal transduction pathways, but also
to transcriptional activation of certain genes corresponding
to the development of T cell subsets.
5.1. PLCγ1 and Calcium Mobilization. As mentioned above,
Itk is a critical activator of PLCγ1. T cells from Itk
−/− mice
display diminished tyrosine phosphorylation of PLCγ1[ 92]Journal of Signal Transduction 7
and of tyrosine 783 in particular [63], the critical activating
site for this lipase. The consequence of PLCγ1 inactivation is
lackofdownstreamsecondarymessengerIP3 bindingtoIP3R
preventingthereleaseofintracellularCa2+ stores[92,93]and
the inhibition of calcium release activated channels (CRAC)
at the plasma membrane [93]. CRAC-mediated capacitative
inﬂux of Ca2+ from extracellular sources prolongs the
signaling necessary for later action, including transcriptional
activity. This sustained Ca2+ inﬂux is necessary for long-
term signaling in the T cell as well as the formation and
the continued presence of the immunological synapse [94].
Accordingly, Itk-deﬁcient T cells are severely diminished
in their short-term and long-term Ca2+ ﬂux abilities. The
failure of sustained Ca2+ﬂux leads to the downstream inacti-
vation of Erk [92], which manifests itself into a lack of NFAT
translocation to the nucleus to initiate its transcriptional
activity.Kinase-inactivemutantsofItkcannotphosphorylate
PLCγ1 and therefore, downstream activation of Erk and
of TCR-induced NFAT reporter activation is compromised
[54]. This inactivation is also due to the lack of PLCγ1g e n -
erated secondary messenger DAG, a necessary component
for the activation of the DAG-binding domain containing
proteinRasGRP ,whichisrequiredforErkpath wayactivation
in T cells [95, 96]. There is some functional redundancy to
theTeckinasesinTcells,asPLCγ1tyrosinephosphorylation,
and subsequent Ca2+ ﬂux is only reduced, and not ablated
in cells lacking Itk, suggesting a functional role for Rlk and
Tec in these processes [92, 93]. T cells from Rlk or Tec
knockout mice do not display these phenotypes, as PLCγ1
phosphorylation and Ca2+ ﬂux are intact. However, T cells
from double knockouts of Itk and Rlk diminish these two
characteristics even further [92]. Further, overexpression of
Tec or Rlk in the absence of Itk can functionally rescue the
Itk-deﬁcient phenotype in T cells [37].
Itk has been established to regulate Ca2+ ﬂux in T cells
through PLCγ1, the lipase that directly leads to the release of
Ca2+ fromERstores.However,thisdoesnotexplainItkeﬀect
on prolonged Ca2+ ﬂux. The recently characterized CRAC
channels would further explain the relationship between Itk
and sustained Ca2+ signaling. How ER-released Ca2+ stores
regulate CRAC channel operation was recently identiﬁed to
be due to an ER-resident Ca2+ sensor named STIM1 [97].
STIM1 knockdown leads to a complete abrogation of store-
operated calcium entry in T cells. Furthermore, upon TCR-
induced activation of the T cell, STIM1 colocalizes with
a plasma membrane resident CRAC channel named Orai1
at the immunological synapse, which leads to a sustained
Ca2+ ﬂux for the T cell [98]. Orai1 is a tetraspanin pore-
forming subunit of the CRAC channel, which when absent
or mutated also causes an abrogation of sustained Ca2+
ﬂux [99, 100]. This mutation (R91W) in Orai1 manifests
in human disease, as one aspect for the development of
SCID is due to the attenuation of Ca2+ ﬂux after T cell
activation [101]. Given Itk’s strong role in sustained Ca2+
ﬂux, it would be of interest to determine whether Itk has an
eﬀect on the activity of either STIM1 or Orai1. Regardless
of a direct or indirect relationship, it might still provide
a more speciﬁc method for temporary therapeutic relief
of some inﬂammatory responses, such as graft rejection
in transplantation, psoriasis, arthritis, or colitis. Current
therapies for these disorders involve the use of cyclosporin A
and FK506 to inhibit calcineurin activity leading to reduced
Ca2+ ﬂux and reduced T cell activity. Unfortunately, since
calcineurin is widely expressed in most cell types, these
treatments often lead to unwanted and sometimes severe
side eﬀects. If one could directly aﬀect Ca2+ ﬂux in T cells
using Itk inhibitors, without aﬀecting other cells, it would be
extremely beneﬁcial for the treatment of these disorders.
5.2. Actin Reorganization. The Tec family kinases were
initially implicated in the regulation of the actin cytoskeleton
through work done in Drosophila. The Tec family kinase
Tec29 was found to be required for the growth of ring
canals, a necessary bridge between the nurse cells and oocyte
during ﬂy embryogenesis [102, 103]. The ring canals in the
Tec29 mutant egg chambers failed to form correctly, thereby
failing to nourish the maturing oocyte. This data shows an
evolutionarily conserved function for Tec kinases in actin
regulation.
Within mammalian T cells, it was discovered by two
groups that Itk was involved in TCR-induced actin poly-
merization [104, 105]. These data showed that in T cells
lacking Itk, actin directed processes (such as lamellipodial
formationanddirectedactinpolymerization)wereimpaired.
The signiﬁcance of this deﬁciency is striking, as the defects
in actin polymerization and polarization in Itk
−/− Tc e l l s
is complete, whereas the Itk defect in Ca2+ ﬂux is only
reduced. Additionally, this defect is most likely entirely due
to the absence of Itk, as T cells deﬁcient for both Itk and
Rlk are just as defective in actin polymerization as Itk
singly deﬁcient T cells, suggesting no functional redundancy
[105]. Further, overexpression of Itk leads to an increase in
membrane ruﬄing (lamellipodia) [44]. This regulation of
actin is through the interaction of Itk with two molecules
directly involved with actin polymerization, Vav1, and WASp
[62, 106]. Vav molecules are GTP exchange factors (GEFs)
that exchange GDP for GTP to activate members of the
Rho GTPase family, particularly that of Cdc42 in T cells.
Vav1 deﬁcient T cells not only display a defect in the
ability to activate the Rho proteins, but also show very
striking actin defects. These cells fail to polymerize actin,
show impaired integrin adhesion and clustering, and display
broader cellular defects than that of T cells lacking either
Itk or WASp [107, 108]. Initially, it was determined that Itk
aﬀected Vav1 localization, as T cells deﬁcient in Itk failed
to localize Vav1 when engaging antigen-pulsed APCs [105].
This defect had a functional consequence, as activated Cdc42
no longer localized to the contact site as measured with a
biosensor. Itk was discovered to constitutively associate with
Vav1 [62], an association that was dependent upon Itk’s SH2
domain. This interaction conﬁrms a hypothesis that Itk has
a kinase-independent function [109], thus broadening the
role of this kinase beyond the simplistic idea that a kinase
must only act as a kinase, that is, to phosphorylate targets.
Notable, however, is the ﬁnding that Vav1 still becomes
tyrosine phosphorylated in cells lacking Itk (although it has
not been determined whether tyrosine 174 phosphorylation8 Journal of Signal Transduction
is defective, the key activating tyrosine in Vav1 [110]), a
ﬁnding compounded by the data that Itk activation is also
abnormal in cells lacking Vav1 [111]. Lately, Itk
−/−Vav1−/−
mice were generated and were shown to be strongly
reduced in the number of double-positive thymocytes and
displayed impaired positive selection [112]. This increased
developmental defect shows that Itk and Vav1 share some
mechanistic similarities aﬀecting T cell development as well.
The Wiskott-Aldrich Syndrome protein (WASp) is the
gene product whose deﬁciency leads to Wiskott-Aldrich
Syndrome, a fulminant state that includes lymphopenia
mediated by a defect in actin regulation. WASp is vital in
actin regulation as it activates the Arp2/3 complex which
helps to nucleate new actin ﬁlaments [113–117]. WASp is
indirectly dependent upon Vav1 for its activation as it needs
to bind to GTP bound Cdc42 to release its autoinhibition
and activate the Arp2/3 complex, leading to the nucleation
of new actin ﬁlaments [24]. Itk has been shown to bind
WASp, both in vitro through its SH3 domain [57]a n din vivo
using full-length molecules [106]; however, the functional
outcome of this interaction is muddied because Itk seems
to be required for WASp’s localization [105], but not for
its phosphorylation [118], a requirement necessary for
WASp’s full activity [119, 120]. Again, this implies a kinase-
independent function for Itk’s role in actin polymerization.
The intricate dance between Itk, Vav1, and WASp, as
it relates to TCR-induced actin polymerization remains an
interesting topic, as it seems that Itk aﬀects both Vav1
and WASp in a kinase-independent manner. This does not,
however, preclude that Itk might have a kinase-speciﬁc role
for the continued activation of these molecules. If Vav1 is
probed for its phosphorylation on its activating tyrosine 174
[121] and if WASp is probed for its phosphorylation on its
activating tyrosine Y291 [119] in the presence or absence
of Itk, one will get a better idea of Itk’s role in a kinase-
dependent or kinase-independent manner. Furthermore, it
has been reported that the Tec family kinase Btk not only
binds actin directly through its PH domain [122], but it
can also tyrosine phosphorylate WASp as well [123, 124].
Also, given that the tyrosine kinase Abl can bind and
phosphorylate actin directly [125], and that the tyrosine
kinase Fyn can phosphorylate WASp [118], it may be useful
topursuewhetherItkcanperformanyofthesedutiesaswell.
The eﬀe c t so fI t ks e e no na c t i np o l y m e r i z a t i o ni nT
cells also dismisses the idea that the cellular defects seen
in Itk
−/− cells is due merely to the molecular inactivation
of PLCγ1. The decrease in actin polymerization can aﬀect
signal strength and signal duration, as well as aﬀect integrin-
mediated adhesion leading to the known defects in Itk
−/−
T cells including altered CD4/CD8 ratios, speciﬁc decrease
in cytokine production, and in the proliferation of these
cells. It is likely that the defect in cytoskeletal reorganization
contributes to the decreased response of Itk
−/− T cells as a
result of ineﬃcient immunological synapse formation [126].
5.3. Adaptor Proteins. As mentioned above, Itk associates
with a plethora of adaptor molecules, most notably, SLP-
76. Itk needs SLP-76 for its phosphorylation and for its
localization to the T cell/APC contact site [9, 58, 63]. The
interaction between Itk and SLP-76 is pivotal, as it helps to
integrate Itk’s functional relationship with many molecules,
including LAT, PLCγ1, and Vav1. The interaction of Itk with
SLP-76 is a complex undertaking, as it is surmised through
in vitro studies that the interaction is a cooperative one
involving SH3 domain of Itk binding to PRR of SLP-76,
and then SH2 domain of Itk binding to phosphorylated
tyrosine 145 of SLP-76, once it has been phosphorylated
by ZAP-70 [54]. This multivalent binding of Itk to SLP-76
provides the means for Itk to associate with another adaptor
moleculenecessaryforitsactivation,LAT.TCR-inducedSLP-
76 signalosome bridging to the LAT signalosome is mediated
by the adaptor protein Gads [127]. SH3 domain of Gads
binding to a PRR motif within SLP-76 separate from that
of Itk indirectly connects SLP-76 to LAT when the latter
becomes phosphorylated and the SH2 domain of Gads can
bind that site. Although Itk does not bind Gads directly, Itk
activation is therefore dependent on Gads ability to unite
SLP-76 and LAT. Itk has been reported to bind LAT directly
in vitro using GST-fusion proteins of the Itk SH2 domain
[128]. This is supported by the evidence that Itk needs
to be localized to the LAT signalosome for its activation
[55]. Further, the association of Itk with LAT may have
functional conformational consequences for Itk’s activation
[129]. This would imply an additional role for LAT, one that
involves more than Itk localization. Therefore, the question
remains whether the binding of Itk to SLP-76 or LAT is more
important for Itk activation. The answer probably is both.
SLP-76 and LAT are integral for the activity of a T cell, so
consequently both are necessary for the activation of Itk.
Lastly, Itk has also been reported to bind another adaptor
molecule, Rlk/Itk binding protein (RIBP) [130, 131], which
has been reported to negatively regulate Itk function, but the
mechanism of this has yet to be determined.
Recently, Itk’s association with SLP-76 in vivo has been
addressed through use of an inhibiting cell-penetrating
peptide [58]. This paper provided the ﬁrst demonstration of
thefunctionalimportanceoftheItk-SH3domaininteraction
with SLP-76 as it relates to Itk’s localization, activation, and
ultimateproductionofTH2cytokines.Thisprovidesamech-
anism of stable Itk-SH3 binding to SLP-76-PRR as a pre-
requisite for the subsequent binding of the Itk-SH2 domain
to the phosphorylated tyrosine 145 on SLP-76, ultimately
coordinating to localize and properly activate Itk [132].
5.4. Regulation of Cellular Adhesion. In order for T cells to
initiate and maintain contact with an APC, functional adhe-
sion through cell surface integrins are necessary. This inte-
grin adhesion requires a functional actin cytoskeleton and
also requires signaling through the TCR. Data from Jurkat
T cells expressing mutant kinase domain Itk shows that Itk
is integral in the activation of β1 integrins through the T cell
receptorinan“inside-out”signalingfunction[133].Further,
blocking TCR-induced T cell activation through inhibition
of Itk leads to a block in β1a n dβ2-integrin adhesion,
and it aﬀects the recruitment of LFA-1 to the site of TCR
stimulation [133].Thisobservation wascarried into primary
mouse T cells by showing that TCR-induced upregulation ofJournal of Signal Transduction 9
β2 integrin adhesion is also severely reduced in cells lacking
Itk [134]. Thus, the TCR-induced maintenance of the T cell
interaction with APC is very much dependent on Itk’s kinase
activity. Although the exact inter-molecular mechanism of
how this cellular interaction regulated through Itk remains
unknown;manyItk-associatingsignalingmoleculesinvolved
in actin reorganization are also associated with integrin
adhesion. Molecules such as PI3K, Vav1, PKCθ, and ADAP
are all connected to integrin signaling, with Itk partnering
PI3K, Vav1, and PKCθ. It is currently unknown whether
Itk associates with ADAP, although given its extraordinary
complicity with integrin signaling and its association with
SLP-76, it would be a natural target to explore for Itk’s
regulation of integrin signaling.
5.5. Transcriptional Regulation. NFATc fails to translocate to
the nucleus when Itk
−/− Tc e l l sb e c o m ea c t i v a t e d[ 135], as
a result of diminished Ca2+ movement in these cells. This
is an expected result because NFAT is activated through
dephosphorylation by the Ca2+ sensitive phosphatase, cal-
cineurin [136]. NFAT is regulated in a highly dynamic Ca2+
dependent manner because as intracellular Ca2+ levels drop,
NFAT quickly becomes phosphorylated and exits from the
nucleus.Consequently,forNFAT-dependenttranscriptionto
occur, quick pulses of ER-derived Ca2+ are not enough to
sustaintranscription.Rather,aprolongedsurgeofCa2+ from
extracellular sources is needed for NFAT to stay active and
promote transcription [137]. Since Itk is involved in capaci-
tative Ca2+ ﬂux, Itk is also involved in prolonged NFAT tran-
scription. NFκB appears not to be defective in Itk-deﬁcient
cells, which is an interesting result as this transcription
factor needs PKC to activate it, which it cannot do without
suﬃcient DAG present [135]. DAG is needed to activate PKC
leading to Erk, and ultimately, to NFκB activation. Though
not measured directly, DAG activity is diminished as PKCθ-
mediated activation of Erk is reduced in Itk
−/− cells, and
therefore one would expect that NFκB activity would also be
compromised. Additionally, the activation of the transcrip-
tion factor AP-1 is reported to be dependent on Itk activity,
a si t sE r kd e p e n d e n ta b i l i t yt ob i n dD N Ai sr e d u c e d[ 138].
Itk is also known to directly phosphorylate the transcription
factor T-bet on tyrosine 525 [36, 139], which may cause the
mostdirectmeansincontrollingTH1dev elopment.W henT -
bet becomes phosphorylated, it proteolytically breaksdown,
leaving GATA-3 expressed, promoting a GATA-3-driven TH2
response.Asmentionedearlier,Itkcanlocalizetothenucleus
uponactivation,putativelyphosphorylatingT-betatthissite.
However, the exact cellular location of this phosphorylation
event as well as the functional signiﬁcance of Itk localization
to the nucleus is still unknown. The functional consequence
of Itk’s phosphorylation of T-bet, however, will be explained
in the context of T cell diﬀerentiation.
6.In Vivo Role of Itk
At ﬁrst glance, the physiological defects in cells lacking Itk
wouldbeconsideredmodestsinceadeﬁciencyinItkhasonly
recently been implicated in any known human disease [140].
However, mice lacking Itk display intriguing and beguiling
results when it comes to cellular function. When compared
to other signaling molecules involved in TCR-induced T cell
signal transduction, Itk defects mirror some, though not
all, defects seen with nearby molecules. The degree of Itk
defects is also variable, placing Itk more as a modulator of
T cell signal pathways, rather than a bridge through which all
signalsmustpass.Table 1 summarizestheinvivoeﬀectsofItk
knockout mice and compares them to other knockout mice
of related molecules (Lck [141], ZAP-70 [142, 143], Rlk [92],
Tec [144], Itk/Rlk double knockout [92], LAT [145–147],
SLP-76 [148, 149], PLCγ1[ 150], WASp [151, 152], PKC-θ
[153–157], Vav1 [107, 108, 158–162], ItpkB [163, 164], Gads
[165], CypA [66, 166]).
6.1. Development. Itk
−/− mice display decreased numbers
of maturing thymocytes reduced proliferative responses and
showed a profound defect in CD4+ T cell development
Figure 3 [167]. Itk
−/− mice have half the number of CD4+
T cells, which when related to Itk molecular signaling, may
be due not only to signal strength, but to signal duration
as well [126]. This again signals Itk’s status as a molecular
rheostat. Proteins upstream and downstream of Itk, Lck, and
Erk1/2, respectively, have both been shown to be important
in lineage commitment [168]. Therefore, it makes sense
that Itk would have defects in this area as well. However,
both CD4+ and CD8+ T cells do emanate from the Itk
−/−
thymus, but at altered ratios due to lower CD4+ numbers
and normal CD8+ numbers (though this does not mean
that the CD8+ cells are normal, as explained later). Thymic
development in both fetal and adult Itk
−/− mice is normal
when analyzed at CD4−CD8− (double-negative, DN) and
CD4+CD8+ (double-positive, DP) stages, although there is
evidence that the time of progression from DN to DP stages
is longer in Itk
−/− thymocytes when compared to wild-type
cells [169] .T h e r ei sar e d u c t i o ns e e ni np e r i p h e r a lC D 4 + T
cells [167], which is due to an impairment in positive selec-
tion in class II MHC TCRs in Itk
−/− T cells [170]. There is
little defect seen in positive selection using the conventional
H-Y TCR system [92, 167]. Class I MHC H-Y TCRs in Itk
−/−
T cells result in decreased eﬃciency of negative selection
[171]. Alternatively, CD8+ T cell peripheral numbers are
higher than controls, indicating that negative selection in the
absence of Itk has failed. Both positive and negative selection
need a functional calcium ﬂux leading to the activation of
Erk1/2 for positive selection [172–174] and p38 activation
for negative selection [175]. Itk
−/− T cells do not possess
an optimal calcium ﬂux and fail to activate Erk1/2, but p38
activation is still intact. Furthermore, in the paper by Huang
et al., positive selection is aﬀected while negative selection
is spared when Itk becomes inactive due to the lack of
secondary messenger IP4 [49]. These data indicate that Itk
would have a more profound impact on positive selection
rather than negative selection. This is conﬁrmed when in the
absence of Itk, the deletion of self-reactive thymocytes under
strong stimulus conditions is impaired, but not under weak
stimulus conditions. Only when Itk-deﬁcient thymocytes
continue to progress to a later stage of development do they
succumb to negative selection signals [170].10 Journal of Signal Transduction
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Figure 3:ThymicTcelldevelopment.CartoondiagramofthedevelopmentofaTcellfromabonemarrow-derivedhematopoieticprogenitor
to that of a mature CD4+ or CD8+ T cell capable of mounting an immune response in the periphery. Itk is necessary for both positive and
negative selection, as it is able to modulate the strength of signal emanating from the T cell receptor.
Although the total numbers of CD8+ Tc e l l sf r o mI t k -
deﬁcient mice appear to be normal, conventional CD8+ T
cells are severely diminished. Instead, an innate or memory
cellular phenotype exists in these mice causing the CD8+ T
cell numbers to appear normal [176, 177]. CD8+ thymocytes
from Itk
−/− mice have a memory cell surface phenotype
(CD44hi, CD62Lhi, CD122hi) and include natural killer
cell markers, such as NK1.1. Additionally, Itk
−/− CD8+ T
cells spontaneously express IFNγ ex vivo and upregulate
antiapoptosis genes such as BCL-XL upon IL-15 stimulation,
which is similar to memory cells. Furthermore, independent
thymic development of CD8+ T cells in Itk
−/− mice is
observed regardless of the type of cell presenting MHC
class I, whereas conventional CD8+ thymic derived T cells
are only selected through interaction with thymic epithelial
MHC class I presentation. Finally, Itk
−/− CD8+ T cells are
dependent on the presence of IL-15 for their survival,
again similar to a memory cell phenotype [178]. The work
to describe the existence of these innate CD8+ Tc e l l s
emanating from Itk
−/− mice was done in the Schwartzberg
lab where they showed these cells arise in Itk
−/− fetal thymic
organ cultures [176]. Furthermore, a molecular marker
for memory CD8+ T cells, eomesodermin, is upregulated
in the absence of Itk [177]. This is interesting because
eomesodermin is known to upregulate the expression of
both the memory cell marker CD122 and the expression
of IFNγ [179]. Finally, the rise of these innate-like CD8+ T
cells is dependent on the adaptor SAP, like NKT cells [180].
Therefore, Itk-deﬁcient mice provide an interesting insight
into the development of CD8+ memory T cells.
6.2. Diﬀerentiation. T helper cell diﬀerentiation is a neces-
sary and crucial developmental process that selectively hones
the T cell response towards certain pathogens (Figure 4).
Initially,thesediﬀerentiatedcellsweredividedintotwotypes,
Th e l p e r1( T H1) and T helper 2 (TH2). This delineation is
evolving to include T helper 17 (TH17) and regulatory T cells
(TReg)a sw e l l .
During TH1d i ﬀerentiation, IL-12, IL-27, or IFNγ sig-
naling through STAT4 and STAT1 induces the expression ofJournal of Signal Transduction 11
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Figure 4: Tc e l ld i ﬀerentiation and their responses to pathogens. Cartoon diagram displaying the interaction of a na¨ ıve CD4+ Tc e l lw i t ha
dendritic cell APC leading to diﬀerentiation into T helper subsets. The development of these subsets allows for protective immunity against
speciﬁc pathogens. Itk is needed to promote TH2 and TH17 diﬀerentiation.
the transcription factor T-bet, which can directly drive TH1
development by increasing IFNγ production and inhibit-
ing IL-4 production. TH2d i ﬀerentiation, by contrast, is
dependent on the IL-4-induced activation of STAT6 leading
to the activity of the transcription factor GATA-3, causing
an increase in IL-4 production and a decrease in IFNγ
production. TH2d i ﬀerentiation was recently described to
occur in two steps when examined in mice expressing
an IL-4 dual reporter gene [181]. The ﬁrst is the TH2
competent stage where cells initially upregulate IL-4 and
GATA-3 gene expression. The second is the TH2e ﬀector
stage where cells support the production and release of
TH2 cytokines necessary for eﬀector function. This two-
step TH2d i ﬀerentiation model was extended by use of an
IL-4-GFP reporter system crossed into Itk-deﬁcient mice
[182]. In these studies, it was found that in the absence of
Itk, TH2d i ﬀerentiation could proceed normally, but when
these diﬀerentiated cells needed to produce and secrete TH2
eﬀector cytokines, they could not do so even with repeated
stimulation. Additionally, under non-skewing conditions
(no exogenous IL-4 added ex vivo to the developing cultures
to promote TH2diﬀerentiation) Itk
−/− cellsdisplaydefectsin
TH2 competent cells, as they preferentially develop into IFNγ
producing TH1 cells [36]. This is an interesting result, as IL-2
receptor signaling is necessary for IL-4 transcription [183],
and since Itk
−/− mice fail to produce substantial amounts of
IL-2 upon stimulation, IL-4 production could be impaired
due to the lack of autocrine IL-2 signaling necessary to
stabilize transcription factor access to the Il4 gene leading to
TH2d i ﬀerentiation [184]. Furthermore, the relative ratios of
Itk and Rlk during T helper cell diﬀerentiation can also be
useful in determining which pathway the cell will take. As
mentionedearlier,na¨ ıveCD4+ Tcellsexpress3–5timesmore
Itk than Rlk when measured by qRT-PCR. When the T cell
becomes activated through its T cell receptor, Rlk becomes
downregulated, leaving 100 times more Itk than Rlk present
[36]. While in this activated state exposure to cytokines
secreted by resident non-T cell leukocytes provides a skewing
environment that drives T helper cell diﬀerentiation, which
is greatly inﬂuenced by the increased ratio of Itk.
TH1a n dT H2e ﬀector cells are also characterized by the
expression of two transcription factors, T-bet in TH1 cells,
GATA-3 in TH2 cells. T-bet is required for the diﬀerentiation
of na¨ ıve T helper cells into TH1 cells and expression of
IFNγ [185], while GATA-3 regulates chromatin remodeling
at the locus that encodes the cytokines IL-4, IL-5, and IL-13,
and consequently promotes TH2d i ﬀerentiation [186, 187].
Itkplaysanactiveroleintheexpressionofthesetranscription
factors, as it phosphorylates T-bet on tyrosine 525 [36, 70].
Phosphorylation of T-bet leads to its proteolytic breakdown,Journal of Signal Transduction 13
leaving only GATA-3 to be expressed, and therefore, a TH2
eﬀector cell diﬀerentiated phenotype.
An intriguing question asked recently is whether Itk
is involved in the regulation of TH17 cellular function.
TH17 cells normally mediate the host defensive response to
extracellular bacterial infections and are reportedly involved
in the pathogenesis of autoimmune diseases through the
overexpression of proinﬂammatory cytokines. The signature
cytokines of TH1a n dT H2 cells, IFNγ and IL-4 respectively,
have both been shown to inhibit TH17 diﬀerentiation [188,
189]. Markedly, while IFNγ normally upregulates T-bet,
the expression of T-bet is signiﬁcantly lower in TH17 cells
[190, 191]. Further, the promotion of TH17 development
leads to the pathogenesis of experimental autoimmune
encephalomyelitis [192]. The TH17 signature cytokine IL-
17 is overexpressed in the airways of asthmatics where it
induces the production of IL-8 chemoattractant needed
by neutrophils, which are phagocytic granulocytes involved
in eliminating bacterial infections [193]. These ﬁndings
draw a connection between Itk, TH17 cells, asthma, and
autoimmunity through the transcription factor T-bet. Since
Itk phosphorylates and aﬀects the downregulation of T-bet,
it would be expected that Itk promotes the development of
TH17 cells. This is indeed the case as shown recently by
Gomez-Rodriguez et al. [194]. It was found in this work
that Itk
−/− T cells produce less IL-17A than their wild-
type counterparts through a reduction in IL17a transcripts,
though interestingly enough, IL17f transcript production
was intact as was the expression of the transcription factor
that regulates TH17 diﬀerentiation, RORγt. This is a fasci-
nating result that implies TH17 diﬀerentiated T cells can be
furthersubdividedintofunctionalsubsets[195].Lastly,since
the presence of Itk helps to promote IL-17A production, the
recent ﬁnding that IL-17A provides a protective function in
a colitis model system suggests that Itk too can be important
in the mediation of intestinal inﬂammation [196].
Another re-emerging set of diﬀerentiated CD4+ Tc e l l s
that have garnered lots of interest lately are regulatory T
cells, or TReg cells. TReg cells have a critical function in the
regulation of peripheral tolerance. It may be that TReg and
TH17 cells are reciprocally regulated through the activation
and deactivation of transcription factors, much like inverse
the relationship between TH1a n dT H2 cells [197]. The
main cytokine produced by TReg cells is IL-10. This cytokine
inhibits the expression of many proinﬂammatory cytokines
and chemokines, helping to decrease the number of
circulating leukocytes from entering the inﬂamed tissue.
Notably, another signiﬁcant defect in Itk-deﬁcient T cells is
the failure to produce IL-10 in response to activation [138].
This was previously interpreted to be part of a diminished
TH2 function. However, given what is now known about the
TReg signature cytokine being IL-10, it would be interesting
to determine the function of these TReg cells in the absence
of Itk. Speculatively, Itk
−/− T cells could have a diminished
TReg response leading to hyperinﬂammatory conditions.
The regulation of the T lymphocyte cytoskeleton by
Itk is through an intricate dance between two additional
cytoskeletal molecules, Vav1 and WASp. Although Itk may
not be integral in the phosphorylation of WASp [118], it is
intimately involved in locating WASp to the immunological
synapse thereby aﬀecting WASp activity [105]. Recently,
it has been discovered that WASp is important in the
development and function of TReg cells, in both mice and
in humans [198–201]. These studies conﬁrm that WASp-
deﬁciency curbed the diﬀerentiation of these cells, as well as
abrogatedtheirsuppressivecellularactivity,suchassuppress-
ingtheproductionofTGFβandIL-10.Giventherelationship
between Itk adaptor function and the localization of WASp
necessary for its activity, a similar interaction in TReg may
indicate that Itk may very well be involved in the manage-
ment of TReg activity, thus aﬀecting autoimmune disorders.
6.3. Cytokine Production. IL-2 production in T cells lacking
Itk is decreased in response to stimulation through the T cell
receptor, which aﬀects these cells ability to proliferate [92,
167, 202]. Exogenous IL-2 enables these cells to overcome
this proliferative defect, a response that originally led to the
name of this kinase [27, 92].
Activationofna¨ ıveCD4+ lymphocytescausestheirdiﬀer-
entiationintoeitherTH1orT H2eﬀectorcells,whichproduce
distinct sets of cytokines. TH1 cells preferentially produce
IFNγ,T N F α, and IL-2, while TH2 cells primarily produce
IL-4, IL-5, and IL-13. The balance between these two sets
of CD4+ eﬀector cells allows for the tuning of the immune
response to the state of infection. Conversely, when this bal-
ance is upset, self-reactive disease states can ensue. An excess
of TH1 cells can lead to autoimmune states, while an excess
of TH2 cells can lead to hypersensitivity. Therefore, T helper
cell diﬀerentiation and cytokine expression regulation is of
paramount importance for an adequate immune response.
Itk
−/− mice display a peculiar cytokine production proﬁle,
as the CD4+ T cells emanating from these mice produce
relatively normal levels of TH1 cytokines (e.g., TNFα and
IFNγ), while TH2 cytokine expression (IL-4, IL-5, and IL-
13) is diminished [135, 203]. IL-4 expression can be rescued
by the retroviral expression of Itk in Itk-deﬁcient cells,
indicating that Itk is the sole reason for the defect in these
cells and not something due to the development of these cells
intheabsenceofItk[135].SinceItk
−/− cellshaveanimpaired
NFATtranscriptionalactivity,itisthereforeexpectedthatIL-
4 and IL-13 cytokine production would be hindered as both
of those cytokines are dependent upon NFAT activity [204].
6.4. Pathogen Clearance. During the course of a viral infec-
tion CD8+ Tc e l l sd i ﬀerentiate into activated killer cytotoxic
T lymphocytes (CTL) whose main functions are the lysis
of infected cells and the secretion of antiviral cytokines,
such as IFNγ and TNFα.C D 8 + Tc e l lf u n c t i o ni nc e l l s
lacking Itk has yielded perplexing results, as Itk
−/− mice
were initially thought to have only a mild defect in their
response to viral infection [205]. When infected with either
lymphocytic choriomeningitis virus (LCMV), vaccinia virus
(VV), or vesicular stomatitis virus (VSV), CTL responses
were reduced two to six-fold. However, the kinetics of
viral clearance was the same in Itk
−/− mice as in wild-
type mice. Further, in the case of anti-VSV-antibodies, the14 Journal of Signal Transduction
serum titers of these antibodies were normal in Itk
−/− mice
when compared to wild-type mice when each had been
infected with VSV. A very interesting recent ﬁnding is the
determination that Itk can aﬀect the replication of human
immunodeﬁciency virus (HIV). Through use of Itk-speciﬁc
siRNA or by using an Itk chemical inhibitor, production of
HIV protein p24, actin-dependent HIV viral entry, and HIV
transcription were all reduced [206]. Although this research
does not imply Itk in the direct clearance of HIV virally
infected cells by CTLs, it does show that by inhibiting Itk
activity, one can ameliorate a viral infection.
T helper cell diﬀerentiation is crucial for the clearance of
pathogens. TH1 cells are important in promoting responses
to clear intracellular pathogens, whereas TH2 cells support
productive humoral immune responses against extracellular
pathogens. Itk
−/− mice display an increased susceptibility to
parasitic infection, as displayed in their inability to clear the
intracellular pathogen Toxoplasma gondii (T. gondii)[ 92],
a parasite that normally induces a protective TH1r e s p o n s e
in wild-type mice. This is odd because T. gondii requires
a fast and robust IFNγ response by the host to prevent
lethality, which Itk
−/− mice produce. This may be due to
the Itk
−/− mouse strain used for these studies since there
are diﬀerences in TH1a n dT H2d i ﬀerentiation among mouse
strains [207, 208]. During a Leishmania major (L. major)
infection, wild-type C57Bl/6 mice are able to produce TH1
cytokines resulting in the clearance of the parasite, whereas
wild-type BALB/c mice primarily produce TH2 cytokines,
which causes them to succumb to the infection. During
an infection that requires a TH1 response by the host to
clear the infection, Itk
−/− mice on C57Bl/6 background elicit
ap r o t e c t i v eT H1r e s p o n s e[ 135]. However, BALB/c mice
deﬁcient for Itk are unable to normally produce a TH1
response, and could not produce a TH2 response due to the
absence of Itk, resulting in the inability of the mice to clear
the infection. The discrepancy between these results may be
because T. gondii infection requires a rapid TH1 response,
while L. major can be cleared by a slow, less robust response.
Therefore, the kinetics of infection and response may dictate
the lethality of the pathogenic infection.
In an attempt to address this issue, the Fowell group
backcrossed the Itk
−/− mice on IL-4-GFP reporter mouse
background [209] to examine an IL-4 producing TH2
response during L. major infection. IL-4 producing CD4+
T cells were present at the site of infection, indicating that
diﬀerentiation and migration to site of infection were not a
problem. However, the amount of IL-4 produced, particu-
larly upon restimulation, was insuﬃcient in the Itk
−/− mice
when compared to the wild-type mice [182]. This elegantly
determines that Itk is not necessarily required for diﬀerenti-
ation, but is required in the production of this cytokine.
Meanwhile, TH2e ﬀector function for protective immu-
nity of extracellular pathogens is more clear. Infection with
Nippostrongylus brasilinensis (N. brasilinensis)c a u s e sap r o -
tective TH2 response in BALB/c mice, while Itk
−/− BALB/c
mice were unable to clear the nematode due to a suboptimal
TH2r e s p o n s e[ 135]. Similarly, Itk
−/− mice on a C57Bl/6
strain background were unable to mount a protective TH2
response to the helminth Schistosoma mansoni (S. mansoni)
due to a severe reduction in TH2 cytokine production of IL-4
and IL-5 [138].
6.5. Allergy Induced Bronchial Asthma. The connection
between Itk and allergic responses was ﬁrst made in a clinical
study on patients with atopic dermatitis, a disease state
characterized by an itchy rash and inﬂammation caused by
an excess of TH2c e l lr e s p o n s e[ 210]. There is an increased
incidence of Itk expression in these patients correlating
to the severity of the disease state. This corresponds well
with elevated Itk expression levels in mouse TH2 cells [36].
Furthermore, the linkage between atopy and Itk can be
traced genetically to the Itk genomic locus as there are single
nucleotide polymorphisms at this locus in atopic patients
[211]. TH2 cellular responses are involved in the pathology
of allergic asthma, as the number of TH2 cells recruited
to the lungs (an immune privileged site) is increased, as
well as the expression of TH2 cytokines and the consequent
movement of responding cells to the lungs resulting in
increased inﬂammation and mucus production [212, 213].
Itk’s ﬁrst direct molecular and cellular correlation to asthma
was made by Mueller and August where they induced airway
hyperresponsiveness in mice and found that Itk
−/− mice
displayed a reduced number of T cells and eosinophils inﬁl-
trating the lungs when compared to similarly treated wild-
type mice [203]. This ﬁnding included a reduction in lung
inﬂammation,diminishedmucusproduction,andreduction
in the TH2 cytokine expression of IL-5 and IL-13. This was
later extended by Ferrara et al. in the ﬁnding that Itk
−/−
mice display a diminished tracheal response to allergen
challenge using the same airway hyperresponsiveness model
system [214]. Mast cells degranulation was also found to be
impaired in Itk
−/− mice in the same model system [215].
On a related issue, mice lacking the transcription factor
T-bet, which Itk normally phosphorylates to promote T-
bet’s degradation, spontaneously develop airway hyperre-
sponsiveness and display enhanced inﬂammation and an
increase in secreted TH2 cytokines [216]. To support this
idea, the August lab recently published work that the Itk
kinase domain activity is necessary for the development of
allergic asthma [217]. Interestingly, T cells from these Itk
kinase domain lacking mice displayed a profound defect
in cytokine mediated T cell migration. Given these results,
competitive inhibitors that selectively target Itk would be
of beneﬁcial therapeutic value in the treatment of asthma.
In fact, one study has shown that by inhibiting Itk kinase
activity, lung inﬂammation in mice can be ameliorated [91].
6.6. Apoptosis. Activation induced cell death (AICD) is the
process by which cells are instructed to commit suicide, or
apoptose, in response to an extracellular signal. This process
is genetically linked as most cells contain signaling pathways
always on the ready for the signal to apoptose. Functionally,
this process is crucial in the life of a lymphocyte, as
stimulation-induced clonal expansion leads to an enormous
number of cells generated to combat an infection, the clear-
ance of the invaders leads to many cells that are no longerJournal of Signal Transduction 15
needed. Apoptosis serves as a means to eliminate these extra
cells, which (if no more pathogen is present) can possibly
be destructive. During instructive thymic development, T
lymphocytes that give too robust a signal to self-antigen
during positive selection are signaled to apoptose in order
to limit self-reactive T cells from entering the periphery. The
apoptotic elimination of clonally expanded T cells after an
infection is also necessary to prevent autoimmunity, as an
a b u n d a n c eo fn ol o n g e rn e e d e dc e l l sc o u l dc a u s ed e s t r u c t i o n
of tissue with similar epitopes [218, 219]. Itk is keenly
involved in the apoptosis of T cells. Itk
−/− T cells have
a decreased susceptibility to CD3-induced apoptosis [92].
Thymocyte deletion, particularly that of double-positive T
cells, is also defective in cells lacking Itk [171]. Furthermore,
Itk is involved with the expression of Fas-ligand as well as
the interaction between Fas-receptor and its downstream
cell death induction molecules [202]. Itk, however, has not
been shown to be involved in anti-Fas engagement leading to
apoptosis. Whether Itk inﬂuences the apoptosis of the large
population of CD8+ memory-like T cells remains to be seen.
6.7. In Vivo Comparison to Other Signaling Molecules. Itk-
deﬁcient cells display many commonalities with cells deﬁ-
cient in other signaling molecules within the TCR-induced
signalosome (Table 1). LAT
−/− mice do not develop mature
T cells, although transgenic point mutant Y136F mice (the
LAT tyrosine motif that PLCγ1 binds to [220]) have a similar
phenotype to that of Itk
−/− mice [145, 146] .T h e s em i c eh a v e
impaired Ca2+ mobilization, TH2 cytokine production, and
increased amounts of IgE in the serum. JNK
−/− mice are also
incapable of clearing a L. major infection, indicating that Itk
couldalsoactthroughtheJNKpathway.TheseJNK-deﬁcient
mice have a reduced IL-4 yield, yet are able to produce
IFNγ when stimulated in vitro under nonskewing conditions
much like that of Itk
−/− mice. Mice deﬁcient in cyclophilin
A (CypA) spontaneously develop allergic disease marked by
increases in IgE antibody titer in serum. These mice also
have an increased inﬁltration of mast cells and eosinophils
into the lungs [66]. TH2 cells emanating from these mice are
hypersensitive to TCR stimulation, and although Itk activity
has not been directly assessed in these cells, given CypA
repressivefunctiononItk,itwouldbeassumedthatItkcould
be hyperactive in these cells. Vav1 and PKCθ deﬁcient T cells
have a decrease in IL-2 production, and consequently, IL-4
production as well [154, 155, 161, 162, 221]. Downstream,
these cells are defective in Ca2+ mobilization leading to
a defect in NFAT transcriptional activation, these cells
are similar to Itk
−/− c e l l sa st h e ya r ed e f e c t i v ei nA P - 1
transcriptionfactoractivation,andthesecellsaredefectivein
NFκB activity. Additionally, mice defective for the expression
of NFAT1 have a decreased TH2 cytokine expression proﬁle
[204]. All of these molecules provide evidence linking the
involvement of Itk in their cellular function.
6.8. Itk Function in Unconventional and Non-T Cells.
Although much of the research on Itk has been produced
in conventional αβ T cells, Itk is expressed in natural killer
(NK) cells, natural killer T (NKT) cells, and mast cells.
natural killer cells are lymphocytes that can eliminate virally
infected cells or transformed cells, independent of an antigen
stimulus as in CTLs. The NK cellular response in Itk
−/−
or in Itk
−/−Rlk
−/− double knockout cells was ﬁrst reported
to be normal, as interpreted from the robust response to
LCMV infection in these mice [35, 205]. However, recently
it was determined that Itk both positively regulates NK cell
cytotoxicity in response to FcR stimulation and negatively
regulates NK cell cytotoxicity upon NKG2D receptor activa-
tion [222]. This indicates a more complex role for Itk in NK
function, one that deserves further exploration. Mast cells
are tissue-resident granulocytes that are the eﬀector cells in
immediate hypersensitivity reactions such as allergic rhinitis.
T h er o l eo fI t ki nm a s tc e l l si sb l u r r e db yt h ep r e s e n c eo fB t k ,
where Btk seems to be the dominant Tec kinase in these cells.
Itk-deﬁcient mast cells elicit little diﬃculty in producing a
cellular response, while Btk-deﬁcient mast cells have much
diﬃculty doing the same in most experimental cases of
hypersensitivity [223]. However, in the speciﬁc context of an
acute allergic response in the lung, Mast cell degranulation
in Itk
−/− mice was signiﬁcantly reduced, irrespective of late
phase TH2-dependent inﬂammatory defects [215]. This is
due to saturating levels of IgE occupancy of FcεRI in these
mice,whichmayinterferewiththedegranulationresponseof
newly secreted IgE [224]. NKT cells are a rare heterogenous
subset of T cells that are important for the initiation and
regulation of an immune response through the ability to
immediatelysecretelargequantitiesofcytokines,particularly
IFNγ and IL-4. Itk has recently been shown to be important
for the development and the homeostasis of NKT cells [225,
226]. Interestingly, not only are NKT cell numbers reduced,
but the continued homeostasis of these cells is dependent on
Itk as NKT cells are diminished even further in Itk
−/− mice
as they age when compared to strain-matched control mice.
Itk is involved in the production of both IFNγ and IL-4 in
NKT cells [227], as Itk-deﬁcient NKT cells fail to produce
either cytokine thus making the cells functionally defective.
This is an interesting ﬁnding because this is diﬀerent from
the TH2-skewed phenotype seen in T cells from Itk-deﬁcient
mice where only IL-4 production is aﬀected. Lately it was
found that although Itk is necessary for the development of
αβ T cells, it was not dispensible for γδ T cells [228]. Itk may
act as a negative regulator for these cells, as their numbers
were increased with respect to wild-type mice, particularly
within the γδ NKT subset. These cells are activated and
provideTcellhelpasseenbyelevatedlevelsofIgE[228,229].
7. Conclusions
Itk can be an ideal therapeutic target for the regulation
of TH2 cell-mediated diseases. Since Itk is the Tec kinase
primarily expressed in TH2 cells, the selective inhibition
of its activity could aﬀect TH2 cell function, including
cytokine expression, without aﬀecting immune responses
against other infections, such as viral or TH1 cell-mediated
pathogens. As such, Itk is a TCR proximal rheostat serving
as a critical molecule that aﬀects signaling and development
in subtle ways, helping to evaluate the strength of the TCR16 Journal of Signal Transduction
signalinordertoproduceaTcellresponsethatisappropriate
for the presented situation.
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